Treatment-refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs

Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Resonance Imaging

(2012) Faisal F. Syed et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of pegylated interferon in hypereosinophilic syndrome

(2011) Joseph H. Butterfield et al.   LEUKEMIA RESEARCH

Refining the definition of hypereosinophilic syndrome

(2010) Hans-Uwe Simon et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update

(2010) Ayalew Tefferi et al.   MAYO CLINIC PROCEEDINGS

How I treat hypereosinophilic syndromes

(2009) A. D. Klion   BLOOD

Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy

(2009) Princess U. Ogbogu et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Success of short-term, higher-dose imatinib mesylate to induce clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome

(2009) Joseph H. Butterfield   LEUKEMIA RESEARCH

Alemtuzumab Therapy for Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia

(2008) S. Verstovsek et al.   CLINICAL CANCER RESEARCH

Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab

(2008) Marc E. Rothenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE